Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-231538
Filing Date
2020-08-27
Accepted
2020-08-26 18:41:58
Documents
4
Period of Report
2020-08-26

Document Format Files

Seq Description Document Type Size
1 6-K d75068d6k.htm 6-K 15312
2 EX-99.1 d75068dex991.htm EX-99.1 7438
3 GRAPHIC g75068g01p01.jpg GRAPHIC 11802
4 GRAPHIC g75068g02p01.jpg GRAPHIC 7809
  Complete submission text file 0001193125-20-231538.txt   50946
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 201138532
SIC: 2836 Biological Products, (No Diagnostic Substances)